SCHEMBL257449

SCHEMBL257449

Bc1ccc(C(=O)O)c(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ ASPH Q12797 1/20 0.44
▸ RXRA P19793 1/20 0.40
▸ RXRB P28702 1/20 0.40
▸ GRIK1 P39086 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ TAS2R14 Q9NYV8 4/20 0.38
▸ NOTUM Q6P988 3/20 0.38
▸ CFTR P13569 1/20 0.38
▸ DAO P14920 1/20 0.37
▸ AKR1C3 P42330 1/20 0.37
▸ AKR1C2 P52895 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940864 0.79 RXRB (0.54) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL31000476 0.79 RXRB (0.54) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3036944 0.78 ASPH (0.59) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7026695 0.78 CES2 (0.50) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL334641 0.78 KEAP1 (0.52) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL424263 0.78 CES2 (0.78) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL187787 0.78 ALDH1A1 (0.57) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL29334051 0.77 ASPH (0.42) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30748715 0.76 ASPH (0.57) CES2KDM4EALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL22164128 0.76 ASPH (0.57) CES2KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 — — WO disclosed
Send feedback